Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

10 avr. 2026 17h13 HE | Source: ReadyRx

ReadyRx NAD+ Rx Claims Evaluated: 2026 Update Highlights Changes in Prescription NAD+ Nasal Spray and Injection Access, Pricing, and Telehealth Eligibility

ReadyRx's 2026 update details prescription NAD+ nasal spray and injection access, compounded therapy structure, pricing, and clinician eligibility.
05 févr. 2026 19h53 HE | Source: PharmaZee

PharmaZee GLP-1 Prescription Information Updated as Novo Nordisk Raises Compounding Concerns and Consumer Interest in Telehealth Semaglutide Access Grows in 2026

PharmaZee telehealth platform information updated. Examining compounded vs FDA-approved GLP-1s amid Novo Nordisk compounding statement Feb 2026.
08 janv. 2026 20h29 HE | Source: ReadyRx

ReadyRx Sermorelin: Prescription Telehealth Access in Injectable and ODT Formats — 2026 Platform Analysis of Compounding Standards and Provider Structure

ReadyRx Sermorelin now available in prescription injectable and ODT tablet formats through telehealth. 2026 platform analysis covers compounding standards.